Home 2023

Roche company

StockWatch: Insilico CEO Breaks Down Exelixis Deal
Artificial Intelligence

StockWatch: Insilico CEO Breaks Down Exelixis Deal

Alex Philippidis -
0
Samsung Biologics Inks Extended Deals Worth $897 Million with Pfizer
Bioprocessing

Samsung Biologics Inks Extended Deals Worth $897 Million with Pfizer

John Sterling -
0
StockWatch: Apellis Wows Analysts with First FDA Approval for GA Therapy
Cancer

StockWatch: Apellis Wows Analysts with First FDA Approval for GA Therapy

Alex Philippidis -
0
Making Medicines Based on Transplanting Differentiated Cells
Drug Discovery

Making Medicines Based on Transplanting Differentiated Cells

Jonathan D Grinstein, PhD -
0
Lineage Cell Therapeutics Makes Medicines Based on Transplanting Differentiated Cells
GEN Edge

Lineage Cell Therapeutics Makes Medicines Based on Transplanting Differentiated Cells

Jonathan D Grinstein, PhD -
0
Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment
Cancer

Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment

Alex Philippidis -
0
Rising Star: Vega Targets Rare Blood Disorders with Antibodies
GEN Edge

Rising Star: Vega Targets Rare Blood Disorders with Antibodies

Alex Philippidis -
0
Monoclonal Antibodies and Continuous Processing: A Case Study Examination
Bioprocessing

Monoclonal Antibodies and Continuous Processing: A Case Study Examination

Kathy Vuksanaj -
0
StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure
Cancer

StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure

Alex Philippidis -
0
Svante Pääbo—First Evolutionary Anthropologist to Win Nobel Prize
Coronavirus

Svante Pääbo—First Evolutionary Anthropologist to Win Nobel Prize

John Sterling -
0
123...52Page 1 of 52
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.